The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

Share Price Information for Idox Group (IDOX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.00
Bid: 64.20
Ask: 65.80
Change: 0.00 (0.00%)
Spread: 1.60 (2.492%)
Open: 65.00
High: 65.00
Low: 64.20
Prev. Close: 65.00
IDOX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year End Trading Update

22 Nov 2023 07:00

RNS Number : 2040U
IDOX PLC
22 November 2023
 

22 November 2023

Idox plc

('Idox', the 'Group' or the 'Company')

Year End Trading Update

A resilient performance in line with expectations

 

Idox plc (AIM: IDOX), a leading supplier of specialist information management software and Geospatial data solutions to the public and asset intensive sectors, today issues a trading update for its financial year ended 31 October 2023 ('FY23').

 

Group trading performance

 

Building on the significant progress the Group has made over the past few years, we are pleased to report Idox has again delivered a resilient performance in line with expectations for FY23 despite the backdrop of continued geo-political and economic uncertainty. We have continued to make good progress towards a number of our medium-term strategic goals, placing the Group on a firm footing for FY24 and beyond.

 

The Group delivered a record order intake of over £82m in FY23, an increase of c.11% on the prior year, reflecting our high-quality customer base and strong market positions.

 

The Board expects to report (subject to external audit) revenue and profit in line with expectations; revenue is expected to be up c.11% to c.£73m, with recurring revenue up c.8% over the period to c.£44m, delivering a c.9% increase in full year adjusted EBITDA to c.£24.5m and a robust adjusted EBITDA margin of c.34% (FY22: 34%).

 

Net debt at 31 October 2023 was £14.7m, including the initial cash consideration of £14.8m paid for Emapsite.com Limited ('Emapsite') as announced on 21 August 2023 (FY22: net debt of £6.7m). In September 2023 the Group completed the refinancing of its lending facilities to a new £75m revolving credit facility and a £45m accordion, a significant increase on the previous facilities which consisted of a revolving credit facility of £35m and £10m accordion, respectively. The new facilities, which are on improved terms, are for a three-year period with two extension options of one year each. The new facilities are provided by the Group's existing syndicate of banks: HSBC Innovation, NatWest and Santander.

 

The integration of Emapsite is underway and will enhance the Group's data capabilities whilst adding significant scale to our Geospatial offering. The Group continues to evaluate a number of further acquisition opportunities, remaining focussed on ensuring strategic alignment at appropriate valuations.

 

We have started FY24 with good levels of visibility - strong recurring revenue, a solid order book and a healthy order pipeline supported by a strengthened financial platform. As a result, our expectations for FY24 remain unchanged, notwithstanding the current macro-environment.

 

David Meaden, Chief Executive Officer of Idox commented:

 

"We are pleased to deliver another solid performance including double-digit revenue growth despite a challenging geo-political and economic backdrop. Our recurring revenue and order intake are both up on the prior year and this provides a solid foundation as we start the new financial year.

 

We are very pleased with the acquisition of Emapsite which adds significant scale and expertise to our existing Geospatial data capabilities. We are excited by the growth opportunities available in this sector, adding to our existing market leading public software capabilities.

 We were delighted to complete a refinancing in the period. The new and increased facilities, which are on improved terms, support our strategic M&A ambitions supplementing our organic growth strategy. Despite the challenging headwinds, our resilient business model allows us to look forward with confidence."

 

 

Notice of results

 

The Group expects to report its FY23 results in late January 2024. Management intends to host a results webinar on the day. Please contact MHP to register your interest.

 

 

Definitions

 

Adjusted EBITDA is defined as earnings before amortisation, depreciation, restructuring, acquisition costs, impairment, financing costs and share option costs.

 

Net debt is defined as the aggregation of cash, bank borrowings and long-term bond.

 

 

For further information please contact:

 

Idox plc

Chris Stone, Non-Executive Chairman

David Meaden, Chief Executive Officer

Anoop Kang, Chief Financial Officer

 

+44 (0) 870 333 7101

investorrelations@idoxgroup.com

Peel Hunt LLP (NOMAD and Broker)

Paul Gillam

Michael Burke

James Smith

 

+44 (0) 20 7418 8900

MHP

Reg Hoare

Ollie Hoare

Matthew Taylor

 

+ 44 (0) 20 3128 8100

idox@mhpgroup.com

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUARRROSUAUUA
Date   Source Headline
14th Aug 20129:37 amRNSDirector/PDMR Shareholding
7th Aug 201210:03 amRNSDirector/PDMR Shareholding
26th Jun 201211:03 amRNSHolding(s) in Company
26th Jun 20127:00 amRNSInterim Management Statement
13th Jun 201210:21 amRNSHolding(s) in Company
29th May 20127:00 amRNSTrading Statement
25th May 20127:00 amRNSContract Win
23rd May 20127:00 amRNSContract win
3rd May 20127:00 amRNSAcquisition
18th Apr 20127:00 amRNSContract win
27th Mar 20122:48 pmRNSHolding(s) in Company
27th Mar 20127:00 amRNSAcquisition
8th Mar 20127:00 amRNSTransaction in Own Shares
1st Mar 20122:40 pmRNSAGM resolutions passed
1st Mar 20127:00 amRNSAGM Statement
23rd Feb 20127:00 amRNSDirector/PDMR Shareholding
14th Feb 20127:00 amRNSContract Win
13th Feb 201212:32 pmRNSHolding(s) in Company
8th Feb 20127:00 amRNSDirector/PDMR Shareholding
6th Feb 20127:00 amRNSNotice of AGM & Annual Report & Accounts
14th Dec 20114:21 pmRNSFinal Dividend
14th Dec 20117:00 amRNSFinal Results
6th Dec 20119:30 amRNSNotice of Results
17th Nov 20113:21 pmRNSHolding(s) in Company
15th Nov 20117:00 amRNSTrading Update
15th Nov 20117:00 amRNSAcquisition
7th Nov 20117:00 amRNSAcquisition
1st Nov 201111:04 amRNSHolding(s) in Company
5th Sep 20113:20 pmRNSTransaction in Own Shares
23rd Aug 20113:35 pmRNSTransaction in Own Shares
17th Aug 201110:50 amRNSHolding(s) in Company
9th Aug 201110:57 amRNSTransaction in Own Shares
9th Aug 201110:56 amRNSAdditional Listing
3rd Aug 20114:54 pmRNSPDMR
21st Jul 20117:00 amRNSGlobal Contract
28th Jun 201112:16 pmRNSHolding(s) in Company
27th Jun 201111:24 amRNSChange of Registered Office
14th Jun 20117:00 amRNSInterim results
14th Jun 20117:00 amRNSHolding(s) in Company
9th Jun 201111:19 amRNSHolding(s) in Company
6th Jun 20114:52 pmRNSHolding(s) in Company
2nd Jun 20111:51 pmRNSHolding(s) in Company
2nd Jun 20111:51 pmRNSHolding(s) in Company
31st May 201111:38 amRNSHolding(s) in Company
27th May 201110:43 amRNSNotice of Results
19th May 201112:28 pmRNSMerger Update
18th May 201111:10 amRNSHolding(s) in Company
18th May 20117:00 amRNSHalf year trading update
13th May 20112:47 pmRNSTransaction in Own Shares
5th May 20117:00 amRNSCompletion of acquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.